Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Heine

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Blood|April 15, 1997
Absence of linkage between type III protein S deficiency and the PROS1 and C4BP genes in families carrying the protein S Heerlen alleleY Espinosa-Parrilla, M Morell, J C Souto, et al.
Cancer Research|October 23, 1997
A region of allelic imbalance in 1q31-32 in primary breast cancer coincides with a recombination hot spotJ Benítez, A Osorio, A Barroso, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 23, 2024
Market Entry Agreements for Innovative Pharmaceuticals Subject to Indication Broadening: A Case Study for Pembrolizumab in The NetherlandsRenaud J S D Heine, Ron H J Mathijssen, Floor A J Verbeek, et al.
The European Journal of Surgery = Acta Chirurgica|August 11, 1998
Analysis of factors affecting outcome after hepatectomy of patients with liver cirrhosis and small hepatocellular carcinomaK J Paquet, H A Gad, A Lazar, et al.
American Journal of Medical Genetics. Part A|September 5, 2003
Fragile-X syndrome and skewed X-chromosome inactivation within a family: a female member with complete inactivation of the functional X chromosomeD Heine-Suñer, L Torres-Juan, M Morlà, et al.
Cytotherapy|October 10, 2022
Towards sustainability and affordability of expensive cell and gene therapies? Applying a cost-based pricing model to estimate prices for Libmeldy and ZolgensmaFrederick W Thielen, Renaud J S D Heine, Sibren van den Berg, et al.
Blood Cells, Molecules & Diseases|May 22, 2013
X-linked thrombocytopenia in a female with a complex familial pattern of X-chromosome inactivationV Daza-Cajigal, N Martínez-Pomar, A Garcia-Alonso, et al.
AIDS and Behavior|July 6, 2016
Suicidal Ideation is Associated with Limited Engagement in HIV CareE Byrd Quinlivan, Bradley N Gaynes, Jennifer S Lee, et al.
Annals of Human Genetics|March 3, 2007
Spectrum of mutations in the CFTR gene in cystic fibrosis patients of Spanish ancestryM J Alonso, D Heine-Suñer, M Calvo, et al.
Plos One|February 1, 2024
Applying a cost-based pricing model for innovative cancer treatments subject to indication expansion: A case study for pembrolizumab and daratumumabR J S D Heine, F W Thielen, R H J Mathijssen, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Blood|April 15, 1997
Absence of linkage between type III protein S deficiency and the PROS1 and C4BP genes in families carrying the protein S Heerlen alleleY Espinosa-Parrilla, M Morell, J C Souto, et al.
Cancer Research|October 23, 1997
A region of allelic imbalance in 1q31-32 in primary breast cancer coincides with a recombination hot spotJ Benítez, A Osorio, A Barroso, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 23, 2024
Market Entry Agreements for Innovative Pharmaceuticals Subject to Indication Broadening: A Case Study for Pembrolizumab in The NetherlandsRenaud J S D Heine, Ron H J Mathijssen, Floor A J Verbeek, et al.
The European Journal of Surgery = Acta Chirurgica|August 11, 1998
Analysis of factors affecting outcome after hepatectomy of patients with liver cirrhosis and small hepatocellular carcinomaK J Paquet, H A Gad, A Lazar, et al.
American Journal of Medical Genetics. Part A|September 5, 2003
Fragile-X syndrome and skewed X-chromosome inactivation within a family: a female member with complete inactivation of the functional X chromosomeD Heine-Suñer, L Torres-Juan, M Morlà, et al.
Cytotherapy|October 10, 2022
Towards sustainability and affordability of expensive cell and gene therapies? Applying a cost-based pricing model to estimate prices for Libmeldy and ZolgensmaFrederick W Thielen, Renaud J S D Heine, Sibren van den Berg, et al.
Blood Cells, Molecules & Diseases|May 22, 2013
X-linked thrombocytopenia in a female with a complex familial pattern of X-chromosome inactivationV Daza-Cajigal, N Martínez-Pomar, A Garcia-Alonso, et al.
AIDS and Behavior|July 6, 2016
Suicidal Ideation is Associated with Limited Engagement in HIV CareE Byrd Quinlivan, Bradley N Gaynes, Jennifer S Lee, et al.
Annals of Human Genetics|March 3, 2007
Spectrum of mutations in the CFTR gene in cystic fibrosis patients of Spanish ancestryM J Alonso, D Heine-Suñer, M Calvo, et al.
Plos One|February 1, 2024
Applying a cost-based pricing model for innovative cancer treatments subject to indication expansion: A case study for pembrolizumab and daratumumabR J S D Heine, F W Thielen, R H J Mathijssen, et al.
Pageof 8